Deutsche Bank Maintains CVS Health Corp to Hold with Price Target $108.00

Brokerage firm Deutsche Bank Maintains its rating on CVS Health Corp(NYSE:CVS). In a research note issued to the investors, the brokerage major Raises the price-target to $108.00 per share. The shares have been rated Hold. The rating by Deutsche Bank was issued on Aug 3, 2016.

In a different note, On Jun 20, 2016, Morgan Stanley said it Downgrades its rating on CVS Health Corp. In the research note, the firm Lowers the price-target to $111.00 per share. The shares have been rated ‘Equal-weight’ by the firm. On May 12, 2016, Jefferies said it Maintains its rating on CVS Health Corp. In the research note, the firm Raises the price-target to $110.00 per share. The shares have been rated ‘Buy’ by the firm. On May 9, 2016, Citigroup said it Maintains its rating on CVS Health Corp. In the research note, the firm Raises the price-target to $105.00 per share. The shares have been rated ‘Neutral’ by the firm.

CVS Health Corp (CVS) made into the market gainers list on Fridays trading session with the shares advancing 0.44% or 0.43 points. Due to strong positive momentum, the stock ended at $97.43, which is also near the day’s high of $97.45. The stock began the session at $97.32 and the volume stood at 23,62,711 shares. The 52-week high of the shares is $108.87 and the 52 week low is $81.37. The company has a current market capitalization of $103,881 M and it has 1,06,62,14,990 shares in outstanding.

CVS Health Corp(CVS) last announced its earnings results on Aug 2, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $43.73B. Analysts had an estimated revenue of $44.28B. Earnings per share were $1.32. Analysts had estimated an EPS of $1.30.

Several Insider Transactions has been reported to the SEC. On May 6, 2016, Larry J Merlo (President and CEO) sold 38,247 shares at $105.00 per share price.Also, On May 6, 2016, Troyen A Brennan (EVP and Chief Medical Officer) sold 7,517 shares at $105.00 per share price.On Apr 5, 2016, Andrew Sussman (EVP & Pres, CVS MinuteClinic) sold 2,844 shares at $105.00 per share price, according to the Form-4 filing with the securities and exchange commission.

CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

CVS Health Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on CVS Health Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.